Stock market analysis with graphs and charts
markets

Brokerages Recommend M&M, UPL, Glenmark for Potential Gains

MUMBAI5 August 2026

Rizz Jobs News Desk·2 min read

Market Briefing

  • Brokerages have shown confidence in stocks like M&M, UPL, and Glenmark Pharma, citing potential upsides despite market volatility.
  • Key recommendations include a 29% potential gain for M&M and 15% for Glenmark.

Brokerages have maintained a positive outlook on a range of stocks across various sectors, including automobiles, pharmaceuticals, IT, chemicals, and batteries, despite recent market volatility. Notable recommendations include Mahindra & Mahindra (M&M), Exide Industries, UPL, Persistent Systems, and Glenmark Pharma.

Morgan Stanley has reiterated its 'Overweight' rating on Mahindra & Mahindra, raising the target price to Rs 4,370 from Rs 4,222. This suggests a potential upside of approximately 29% from the current market price of Rs 3,385. Meanwhile, Citi has maintained its 'Buy' rating on Exide Industries, with a target price of Rs 510, indicating a potential upside of about 14% from the current price of Rs 444.

Equirus Securities continues to hold a 'Long' stance on UPL, setting a target price of Rs 710. This reflects a potential upside of around 13% from the current market price of Rs 625. Motilal Oswal has retained its 'Buy' rating on Persistent Systems, with a target price of Rs 6,400, suggesting a potential upside of nearly 15% from the current market price of Rs 5,575.

Additionally, Motilal Oswal has maintained its 'Buy' rating on Glenmark Pharma, with a target price of Rs 2,570, implying a potential upside of around 15% from the current market price of Rs 2,230.

These recommendations reflect the confidence of brokerage firms in the growth potential of these companies, despite the recent fluctuations in the stock market. Investors are advised to consider these insights while making investment decisions.

Background

The stock market has experienced volatility recently, prompting investors to seek guidance from brokerage firms. These recommendations are based on thorough analysis and reflect the firms' confidence in the long-term growth potential of these companies.

Looking ahead, market participants should keep an eye on these stocks as they have been identified for their potential to deliver significant returns. Continued monitoring of market conditions and company performance will be crucial for investors aiming to capitalize on these opportunities.

Share this story

Topics

stock recommendationsM&MExide IndustriesUPLGlenmark Pharma

Stay Informed

India's financial news, delivered daily.

Finance, markets, economy and startup updates — straight to your inbox.

Subscribe Free →